Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for $600 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback